Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma.

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Clin Exp Metastasis. 2007; 24(7):533-40.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.